Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 76

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 5
Chunk 76
---
In addition, in October 2023, a 14-year-old with a gun opened fire in a luxury shopping mall in downtown Bangkok, killing two people and
injuring five in one of Thailand’s most popular tourist destinations. These conditions may cause NewGenIvf difficulty in attracting
clients from the PRC to travel to Thailand, Cambodia and Kyrgyzstan for NewGenIvf’s services, which could materially and adversely
affect NewGenIvf’s operations and financial results.

Given the uncertainty of
the local and global conditions and the countries’ future policy regarding international traveling, all of which are beyond NewGenIvf’s
control, NewGenIvf’s results of operation may be materially and adversely affected by any changes in international travelling conditions.

Key Components of Results of Operations

NewGenIvf’s revenues
were derived from two types of services: IVF treatment services and surrogacy and ancillary caring services.

Revenue

The following table sets
forth a breakdown of NewGenIvf’s revenue by the types of services, in absolute amounts and as percentages of total revenue, for
the periods indicated.

                                               For the Year ended December 31,                                                                
                                               2024                                                           2023                            
                                               US$                                                            US$                             
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  IVF treatment services (1)                                                        5,433,375      100.0                4,021,696       78.3  
  Surrogacy and ancillary caring services                                           -              -                    1,114,457       21.7  
  Total revenues                                                                    5,433,375      100.0                5,136,153      100.0  

  (1)      Include an insignificant amount of revenue derived from consultation customers who used NewGenIvf’s non-IVF treatment and insignificant services, such as check-ups services, blood test services...  

NewGenIvf generated revenue
from facilities located in various geographic regions. The following table sets forth a breakdown of NewGenIvf’s revenue based on
the locations where the revenue originated, in absolute amounts and as percentages of total revenue, for the periods indicated.

                      For the Year ended December 31,                                                                
                      2024                                                           2023                            
                      US$                                                            US$                             
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  HK SAR                                                           -